How big is Carisma Therapeutics, Inc.?

Jun 22 2025 06:30 PM IST
share
Share Via
As of Jun 18, Carisma Therapeutics, Inc. has a market capitalization of 18.80 million, categorizing it as a Micro Cap company. As of Jun 24, net sales for the latest four quarters are 19.96 million, with a net profit of -50.77 million.
As of Jun 18, Carisma Therapeutics, Inc. has a market capitalization of 18.80 million, categorizing it as a Micro Cap company.

As of Jun 24, the sum of net sales for the latest four quarters is 19.96 million, while the sum of net profit for the same period is -50.77 million.

As of Dec 24, the shareholder's funds are reported at -27.91 million, and total assets amount to 30.46 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
What does Carisma Therapeutics, Inc. do?
Jun 22 2025 07:20 PM IST
share
Share Via